Amyotrophic Lateral Sclerosis (ALS) stem cell treatment may be able to postpone progression of the disease. ALS has no known cure, and the current prognosis is two to four years from onset. Recent advances in stem cell technology have provided researchers with new tools to combat ALS, as well as potential new treatments for patients.
Amyotrophic Lateral Sclerosis (ALS) is a difficult disease to comprehend and treat. Every year, it affects one to two people out of every 100,000 in the United States.
Approximately 95 per cent of ALS cases are caused by unknown factors, with only about five per cent being genetically inherited from parents. Although ALS typically strikes people between the ages of 50 and 60, it can affect people of any age.
Clinical trials have shown that mesenchymal stem cells (MSCs) are a promising approach to treating ALS; MSC transplantation may delay disease onset and progression, increasing lifespan. Motor neuron loss may also be reduced, resulting in a delay in motor function loss. The research results of preclinical studies have encouraged the use of MSCs in ALS patients.
Stem cell therapy for ALS may play a supportive role by creating a nurturing and neuroprotective microenvironment for diseased motor neurons, thereby slowing neurodegeneration and neuronal death.
Transplanted stem cells with this ability secrete neurotrophic factors, differentiate into non-diseased, non-neuronal cells like astrocytes and microglia, or differentiate into modulatory neurons that synapses with diseased motor neurons (MN). Preclinical research is promising and has shown that stem cells have the potential to treat ALS.
The idea behind ALS stem cell treatment is to improve the diseased microenvironment. Transplanted stem cells secrete neurotrophic factors and differentiate into supportive cells like astrocytes and microglia, creating a neuroprotective environment that can slow motor neuron degeneration.
Stem cell therapy for amyotrophic lateral sclerosis (ALS) could be an effective treatment option. Stem cells are a promising and viable way of sustaining and nourishing diseased motor neurons.
The idea behind stem cell therapy for ALS is to improve the diseased microenvironment. While stem cells cannot directly replace diseased motor neurons, they can secrete neurotrophic factors and differentiate into supportive cells such as astrocytes and microglia, creating a neuroprotective milieu that can slow motor neuron degeneration.
Researchers have turned to stem cells in the fight against ALS for one main reason:
Stem cells are being employed in clinical trials to treat ALS directly, they can detect damage in the body and replace cells of any sort. As a result, stem cell transplants are being employed to both safeguard a patient’s healthy neurons and create new cells to replace those that have died.
Stemwell uses cord tissue-derived mesenchymal stem cells ethically sourced from full-term human umbilical cords. We administer more than 300 million cells that are all thoroughly tested for viability before treatment. These cells are NOT a blood product; therefore, it is extremely safe and does not require HLA or phenotypic matching.
Video call with one of our doctors, where patient’s condition and medical history will be discussed.
The patient undergoes an initial evaluation and blood work by Stemwell’s doctor. The patient is later sent to rest at their hotel.
Application of 3 Million x Kg of weight distributed in 2 intrathecal applications, under sedation in the surgery room and two endogenous applications.
Oral Detox in children.
5 sessions – Hyberbaric chamber
(xxmin per session)
5 sessions – Transcranial Magnetotherapy
(45min per session)
5 sessions Biophotomodulation
(30min per session)
Amyotrophic Lateral Sclerosis (ALS) occurs when the body starts experiencing the death of neurons controlling voluntary muscles.
Because ALS affects both upper and lower motor neurons, patients with the disease experience both involuntary spasticity and muscle weakness over time. This involuntary spasticity exacerbates symptoms.
Amyotrophic Lateral Sclerosis, or ALS, is a difficult disease to comprehend and treat. Every year, it affects one to two people out of every 100,000 in the United States.
Our mission is to bring hope, healing, and a personalized plan to every patient we meet. We believe the caring hands and expertise of our doctors along with our proven protocols provide the best possible outcomes. We follow the highest ethical international standards offering transparency, honesty, and clinical accuracy.
AddressCra. 13 #118-08, Bogotá, Colombia
Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other medical treatments. Reviewing the patient’s medical history is necessary to determine stem cell therapy eligibility. Any personal information provided is for internal and medical use with our medical providers only. The Stemwell Health headquarters is located in McLean, Virginia. Stemwell Health Virginia is not a stem cell treatment facility or surgical center. Treatments are not conducted anywhere in the US, since these advanced therapies are not yet FDA-approved. All cell therapies are conducted in Colombia where it is regulated by the ministry of health, INVIMA (Columbia’s FDA equivalent) and other local authorities. All treatments are performed within the country’s legal limits and regulatory framework where the specific medical provider practices.